Bendszus M - Search Results

1

Arterial hypertension and bevacizumab treatment in glioblastoma: no correlation with clinical outcome.

Wick A, Schäfer N, Dörner N, Schemmer D, Platten M, Bendszus M, Wick W. Wick A, et al. Among authors: bendszus m. J Neurooncol. 2010 Mar;97(1):157-8. doi: 10.1007/s11060-009-0003-5. Epub 2009 Aug 29. J Neurooncol. 2010. PMID: 19727565 No abstract available.

2

[Neuroradiological response criteria for malignant gliomas].

Bendszus M, Platten M. Bendszus M, et al. Nervenarzt. 2010 Aug;81(8):950-5. doi: 10.1007/s00115-010-2959-y. Nervenarzt. 2010. PMID: 20669003 Review. German.

3

Comment to: Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma: pitfalls in perfusion MRI in brain tumors : Tsien C, Galbán CJ, Chenevert TL, Johnson TD, Hamstra DA, Sundgren PC, Junck L, Meyer CR, Rehemtulla A, Lawrence T, Ross BD. J Clin Oncol. 2010;28:2293-9.

Radbruch A, Bendszus M, Wick W, Heiland S. Radbruch A, et al. Among authors: bendszus m. Clin Neuroradiol. 2010 Aug;20(3):183-4. doi: 10.1007/s00062-010-0024-7. Clin Neuroradiol. 2010. PMID: 20734016 No abstract available.

4

Perfusion magnetic resonance imaging for parametric response maps in tumors: is it really that easy?

Heiland S, Wick W, Bendszus M. Heiland S, et al. Among authors: bendszus m. J Clin Oncol. 2010 Oct 10;28(29):e591; author reply e592. doi: 10.1200/JCO.2010.30.3586. Epub 2010 Sep 13. J Clin Oncol. 2010. PMID: 20837945 No abstract available.

5

Bevacizumab does not increase the risk of remote relapse in malignant glioma.

Wick A, Dörner N, Schäfer N, Hofer S, Heiland S, Schemmer D, Platten M, Weller M, Bendszus M, Wick W. Wick A, et al. Among authors: bendszus m. Ann Neurol. 2011 Mar;69(3):586-92. doi: 10.1002/ana.22336. Ann Neurol. 2011. PMID: 21446027

6

Does age matter? - A MRI study on peritumoral edema in newly diagnosed primary glioblastoma.

Seidel C, Dörner N, Osswald M, Wick A, Platten M, Bendszus M, Wick W. Seidel C, et al. Among authors: bendszus m. BMC Cancer. 2011 Apr 12;11:127. doi: 10.1186/1471-2407-11-127. BMC Cancer. 2011. PMID: 21481277 Free PMC article.

7

Relevance of T2 signal changes in the assessment of progression of glioblastoma according to the Response Assessment in Neurooncology criteria.

Radbruch A, Lutz K, Wiestler B, Bäumer P, Heiland S, Wick W, Bendszus M. Radbruch A, et al. Among authors: bendszus m. Neuro Oncol. 2012 Feb;14(2):222-9. doi: 10.1093/neuonc/nor200. Epub 2011 Dec 6. Neuro Oncol. 2012. PMID: 22146386 Free PMC article.

8

Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment.

Weiler M, Pfenning PN, Thiepold AL, Blaes J, Jestaedt L, Gronych J, Dittmann LM, Berger B, Jugold M, Kosch M, Combs SE, von Deimling A, Weller M, Bendszus M, Platten M, Wick W. Weiler M, et al. Among authors: bendszus m. Oncogene. 2013 Feb 28;32(9):1099-109. doi: 10.1038/onc.2012.137. Epub 2012 May 7. Oncogene. 2013. PMID: 22562250 Free article.

9

[Clinically isolated syndrome].

Platten M, Lanz T, Bendszus M, Diem R. Platten M, et al. Among authors: bendszus m. Nervenarzt. 2013 Oct;84(10):1247-59. doi: 10.1007/s00115-013-3845-1. Nervenarzt. 2013. PMID: 24081277 Review. German.

10

Towards optimizing the sequence of bevacizumab and nitrosoureas in recurrent malignant glioma.

Wiestler B, Radbruch A, Osswald M, Combs SE, Jungk C, Winkler F, Bendszus M, Unterberg A, Platten M, Wick W, Wick A. Wiestler B, et al. Among authors: bendszus m. J Neurooncol. 2014 Mar;117(1):85-92. doi: 10.1007/s11060-013-1356-3. Epub 2014 Jan 24. J Neurooncol. 2014. PMID: 24458956 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

789 results

Search Page

Filters